Can you provide the average price target for CLENE INC stock?
12 analysts have analysed CLNN and the average price target is 32.64 USD. This implies a price increase of 502.21% is expected in the next year compared to the current price of 5.42.
NASDAQ:CLNN • US1856342019
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CLENE INC (CLNN).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2026-03-12 | D. Boral Capital | Maintains | Buy -> Buy |
| 2026-01-09 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-12-10 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-12-03 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-11-17 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-09-25 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-09-10 | Benchmark | Maintains | Buy -> Buy |
| 2025-08-21 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-18 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-14 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-07-18 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-30 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-08 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-08 | Benchmark | Maintains | Buy -> Buy |
| 2025-04-23 | Jones Trading | Initiate | Buy |
| 2025-04-08 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-04-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-24 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-12 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-25 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 654K 39.15% | 342K -47.71% | 200K -41.52% | 224.4K 12.20% | 46.148M 20,465.06% | 169.08M 266.39% | 402.26M 137.91% | 661.84M 64.53% | 946.78M 43.05% | 1.244B 31.39% | 1.649B 32.56% | |
| EBITDA YoY % growth | -38.835M 18.05% | -31.448M 19.02% | N/A 32.21% | -33.966M -59.33% | -33.864M 0.30% | -3.417M 89.91% | 149.02M 4,461.14% | 296.21M 98.77% | 565.79M 91.01% | 724.1M 27.98% | 821.2M 13.41% | |
| EBIT YoY % growth | -40.54M 16.26% | -33.093M 18.37% | -23.083M 30.25% | -29.617M -28.31% | -19.976M 32.55% | 117.45M 687.94% | 246.29M 109.70% | 427.17M 73.44% | 641.57M 50.19% | 807.8M 25.91% | 1.118B 38.40% | |
| Operating Margin | -6,198.78% | -9,676.32% | -11,541.50% | -13,198.18% | -43.29% | 69.46% | 61.23% | 64.54% | 67.76% | 64.94% | 67.80% | |
| EPS YoY % growth | -10.40 -13.04% | -5.94 42.88% | -2.60 56.23% | -2.12 18.40% | -0.90 57.69% | 0.52 157.95% | 5.95 1,043.14% | 11.21 88.59% | 18.58 65.67% | 23.17 24.70% | 26.44 14.11% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.58 -549.77% | -0.59 23.72% | -0.67 20.80% | -0.63 28.52% |
| Revenue Q2Q % growth | 39.78K -50.89% | 73.103K 170.75% | 73.103K 387.36% | 73.103K -5.06% |
| EBITDA Q2Q % growth | -5.457M -48.61% | -10.608M -108.24% | -13.668M -202.86% | -13.872M -130.51% |
| EBIT Q2Q % growth | -7.02M -72.23% | -8.282M -41.24% | -9.485M -67.93% | -9.825M -31.09% |
All data in USD
12 analysts have analysed CLNN and the average price target is 32.64 USD. This implies a price increase of 502.21% is expected in the next year compared to the current price of 5.42.
CLENE INC (CLNN) will report earnings on 2026-05-05.
The consensus EPS estimate for the next earnings of CLENE INC (CLNN) is -0.58 USD and the consensus revenue estimate is 39.78K USD.
The number of analysts covering CLENE INC (CLNN) is 12.